Annexon, Inc. (ANNX) Financials

ANNX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 203.8 million 47.0 million
2023-06-30 233.0 million 48.3 million
2023-03-31 268.8 million 53.9 million
2022-12-31 285.1 million 53.9 million

ANNX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -28.3 million 4.5 million
2023-06-30 -36.4 million 4.7 million
2023-03-31 -33.1 million 4.6 million
2022-12-31 -27.4 million 4.8 million

ANNX Net Income

No data available :(

ANNX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 165.3 million - 31.5 million
2023-06-30 192.9 million - 32.0 million
2023-03-31 228.2 million - 32.5 million
2022-12-31 242.7 million - 32.9 million

ANNX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 75.3 million
2023-06-30 75.2 million
2023-03-31 73.9 million
2022-12-31 72.4 million

ANNX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 19000 27.9 million 6.9 million -
2023-06-30 30000 30.3 million 7.0 million -
2023-03-31 137000 32.3 million 8.9 million -
2022-12-31 282000 28.5 million 8.2 million -

ANNX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 823000
2023-06-30 - 810000
2023-03-31 - 800000
2022-12-31 - 1.0 million

ANNX

Price: $4.70

52 week price:
1.57
8.40

Earnings Per Share: -1.77 USD

P/E Ratio: -2.69

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 124730

Market Capitalization: 505.0 million

Links: